Publication Date
In 2025 | 0 |
Since 2024 | 0 |
Since 2021 (last 5 years) | 0 |
Since 2016 (last 10 years) | 1 |
Since 2006 (last 20 years) | 2 |
Descriptor
Check Lists | 2 |
Comparative Analysis | 2 |
Pain | 2 |
Aggression | 1 |
Attention Deficit… | 1 |
Autism | 1 |
Behavior Problems | 1 |
Cognitive Processes | 1 |
Developmental Disabilities | 1 |
Drug Therapy | 1 |
Eating Disorders | 1 |
More ▼ |
Author
Agaoglu, Belma | 1 |
Black, William R. | 1 |
Courtemanche, Andrea B. | 1 |
Karakaya, Isik | 1 |
Memik, Nursu Cakin | 1 |
Reese, R. Matthew | 1 |
Sismanlar, Sahika G. | 1 |
Yildiz, Ozlem | 1 |
Publication Type
Journal Articles | 2 |
Reports - Evaluative | 1 |
Reports - Research | 1 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Courtemanche, Andrea B.; Black, William R.; Reese, R. Matthew – American Journal on Intellectual and Developmental Disabilities, 2016
Research has suggested that individuals who engage in self-injurious behavior may have enhanced expressions of pain, which contradicts previous assertions of blunted pain sensitivity in this population. The purpose of this study was to measure expressions of pain among young children being evaluated for autism and other neurodevelopmental…
Descriptors: Injuries, Self Destructive Behavior, Behavior Problems, Young Children
Yildiz, Ozlem; Sismanlar, Sahika G.; Memik, Nursu Cakin; Karakaya, Isik; Agaoglu, Belma – Child Psychiatry and Human Development, 2011
The aim of this study was to compare the safety, efficacy, tolerability, and the effects of atomoxetine and OROS-MPH on executive functions in children with ADHD. This study was an open-label study that only included two medication groups. Children were randomized to open-label atomoxetine or OROS-MPH for 12 weeks. Primary efficacy measures were…
Descriptors: Pain, Safety, Attention Deficit Hyperactivity Disorder, Patients